Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation. 1986

D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg

Peripheral blood mononuclear cells from 25 patients with measles and 13 patients with other diseases from Lima, Peru, were studied by immunocytochemical staining for cell surface antigens indicating the type of cell (Leu 4, Leu 3, T8, B1, M1, or esterase) and the state of cell activation (T10 and IL-2 receptor). Measles patients were studied during the first 2 weeks of disease and had no alteration in the proportion of cells which were positive for any subset marker or in the ratio of helper/inducer to cytotoxic/suppressor T cells compared to controls. Measles patients, however, had a greater number of cells expressing the activation antigens T10 and IL-2 receptor than controls. Incorporation of [3H]thymidine was also higher in measles patients when exogenous natural or recombinant IL-2 was added to unstimulated cultured cells. We conclude that the peripheral blood mononuclear leukocytes of patients with measles have normal proportions of helper/inducer and cytotoxic/suppressor T lymphocytes, B lymphocytes, and monocytes but that an increased number of these cells are in an activated state.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003141 Communicable Diseases An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host. Infectious Diseases,Communicable Disease,Disease, Communicable,Disease, Infectious,Diseases, Communicable,Diseases, Infectious,Infectious Disease

Related Publications

D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
July 2007, Clinical and vaccine immunology : CVI,
D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
April 1989, The Journal of infectious diseases,
D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
January 1988, Neurologia i neurochirurgia polska,
D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
February 2014, Journal of virology,
D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
February 1989, Journal of virology,
D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
May 1990, Clinical immunology and immunopathology,
D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
September 1975, The Journal of experimental medicine,
D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
October 2006, Pediatrics,
D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
January 1987, Journal of cancer research and clinical oncology,
D E Griffin, and T R Moench, and R T Johnson, and I Lindo de Soriano, and A Vaisberg
September 1993, Journal of hepatology,
Copied contents to your clipboard!